despite similar levels of hypercalcemia , sbgp was increased in primary hyperparathyroidism ( 14.2 +/- 9.6 ng/ml , p less than 0.001 ) , was decreased in malignant hypercalcemia ( 3.1 +/- 2.8 ng/ml , p less than 0.001 ) , and was normal in patients with bone metastases without hypercalcemia ( 6.6 +/- 2.7 ng/ml ) .
C0149911
malignant hypercalcemia
C0020437
hypercalcemia